Integer Holdings (ITGR) & AxoGen (NASDAQ:AXGN) Head to Head Analysis
Integer Holdings (NASDAQ: ITGR) and AxoGen (NASDAQ:AXGN) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, risk, valuation, profitabiliy, analyst recommendations and institutional ownership.
Valuation & Earnings
This table compares Integer Holdings and AxoGen’s gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Integer Holdings||$1.40 billion||0.97||$270.28 million||N/A||N/A|
|AxoGen||$45.24 million||12.25||-$8.23 million||($0.45)||-37.22|
Integer Holdings has higher revenue and earnings than AxoGen.
This is a summary of current ratings and target prices for Integer Holdings and AxoGen, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Integer Holdings presently has a consensus target price of $35.00, indicating a potential downside of 19.63%. AxoGen has a consensus target price of $14.38, indicating a potential downside of 14.18%. Given AxoGen’s stronger consensus rating and higher probable upside, analysts clearly believe AxoGen is more favorable than Integer Holdings.
Insider and Institutional Ownership
63.7% of AxoGen shares are held by institutional investors. 9.3% of AxoGen shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
This table compares Integer Holdings and AxoGen’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Volatility and Risk
Integer Holdings has a beta of 1.3, suggesting that its stock price is 30% more volatile than the S&P 500. Comparatively, AxoGen has a beta of 0.27, suggesting that its stock price is 73% less volatile than the S&P 500.
Integer Holdings Company Profile
Greatbatch, Inc. is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise. Greatbatch Medical’s products include medical devices and components for the cardiac, neuromodulation, orthopedics, portable medical, vascular and energy markets. QiG focuses on developing medical device systems for some of healthcare’s challenges and reflects the Company’s strategic evolution of its product offerings in order to raise the growth and profitability profile of the Company. QiG utilizes a diversified portfolio approach with three investment modes: new medical device systems commercialization, collaborative programs with OEM customers and strategic equity positions in emerging healthcare companies.
Receive News & Ratings for Integer Holdings Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer Holdings Co. and related companies with MarketBeat.com's FREE daily email newsletter.